Quantification in Complex Matrices
Quantification: Assay development, validation of substances in plasma / urine / tissue escorting clinical phases I-III (bioavailability as well as bioequivalence), preclinical phase and early stage investigation.
We quantify drugs, narcotics, metabolites and endogenous substances in virtually any biological matrix. Based on decades of experience and state of the art equipment we develop methods with extremely high sensitivity (down to femtogram/mL in plasma) and maximal selectivity. We have remarkable expertise analyzing inhalative drugs.
Since 2003, acquired and generated data is being stored in an industry-standard, fully certified and validated electronic archive that meets European Commission and FDA (21 CFR Part 11) requirements.
Sample quantities range from high throughput (thousands of samples) down to studies with just a few samples.
Our sponsors are Medium and Big Pharma as well as biotechs.